 | • レポートコード：C-GIR20G0093 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「未分化リンパ腫キナーゼ阻害剤の世界市場2019年」は、グローバルにおける未分化リンパ腫キナーゼ阻害剤市場を展望するレポートです。未分化リンパ腫キナーゼ阻害剤のグローバル市場概観、メーカー動向、メーカー別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・未分化リンパ腫キナーゼ阻害剤の市場概観 ・未分化リンパ腫キナーゼ阻害剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・未分化リンパ腫キナーゼ阻害剤の企業別販売動向、市場シェア、市場集中度、競争動向 ・未分化リンパ腫キナーゼ阻害剤の世界市場規模 ・未分化リンパ腫キナーゼ阻害剤の北米市場分析（アメリカ、カナダ、メキシコ等） ・未分化リンパ腫キナーゼ阻害剤のアメリカ市場規模推移 ・未分化リンパ腫キナーゼ阻害剤のカナダ市場規模推移 ・未分化リンパ腫キナーゼ阻害剤のメキシコ市場規模推移 ・未分化リンパ腫キナーゼ阻害剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・未分化リンパ腫キナーゼ阻害剤のドイツ市場規模推移 ・未分化リンパ腫キナーゼ阻害剤のイギリス市場規模推移 ・未分化リンパ腫キナーゼ阻害剤のロシア市場規模推移 ・未分化リンパ腫キナーゼ阻害剤のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・未分化リンパ腫キナーゼ阻害剤の日本市場規模推移 ・未分化リンパ腫キナーゼ阻害剤の中国市場規模推移 ・未分化リンパ腫キナーゼ阻害剤の韓国市場規模推移 ・未分化リンパ腫キナーゼ阻害剤のインド市場規模推移 ・未分化リンパ腫キナーゼ阻害剤の東南アジア市場規模推移 ・未分化リンパ腫キナーゼ阻害剤の南米市場分析（ブラジル、アルゼンチン等） ・未分化リンパ腫キナーゼ阻害剤の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・未分化リンパ腫キナーゼ阻害剤の種類別分析/販売量、売上、市場シェア（クリゾチニブ、セリチニブ、塩酸アレクチニブ） ・未分化リンパ腫キナーゼ阻害剤の用途別分析/市場規模（NSCLC、乳がん、大腸がん、神経芽細胞腫、卵巣がん、その他） ・未分化リンパ腫キナーゼ阻害剤の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・未分化リンパ腫キナーゼ阻害剤の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Anaplastic Lymphoma Kinase Inhibitors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Anaplastic Lymphoma Kinase Inhibitors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Pfizer, Inc.
Takeda Pharmaceutical Co., Ltd.
Helsinn Therapeutics
Crtierium, Inc.
Betta Pharmaceutcials Co., Ltd.
F.Hoffman-La Roche Ltd.
Tesaro, Inc.
Oncoethix GmbH
Novartis AG.
Xcovery Holding Company, LLC
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Crizotinib
Ceritinib
Alectinib Hydrochloride
Market Segment by Applications, can be divided into
NSCLC
Breast Cancer
Colorectal Cancer
Neuroblastoma
Ovarian Cancer
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anaplastic Lymphoma Kinase Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anaplastic Lymphoma Kinase Inhibitors, with price, sales, revenue and global market share of Anaplastic Lymphoma Kinase Inhibitors in 2017 and 2018.
Chapter 3, the Anaplastic Lymphoma Kinase Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anaplastic Lymphoma Kinase Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Anaplastic Lymphoma Kinase Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Anaplastic Lymphoma Kinase Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Anaplastic Lymphoma Kinase Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Crizotinib
1.2.2 Ceritinib
1.2.3 Alectinib Hydrochloride
1.3 Market Analysis by Applications
1.3.1 NSCLC
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Neuroblastoma
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer, Inc.
2.1.1 Business Overview
2.1.2 Anaplastic Lymphoma Kinase Inhibitors Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer, Inc. Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Takeda Pharmaceutical Co., Ltd.
2.2.1 Business Overview
2.2.2 Anaplastic Lymphoma Kinase Inhibitors Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Takeda Pharmaceutical Co., Ltd. Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Helsinn Therapeutics
2.3.1 Business Overview
2.3.2 Anaplastic Lymphoma Kinase Inhibitors Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Helsinn Therapeutics Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Crtierium, Inc.
2.4.1 Business Overview
2.4.2 Anaplastic Lymphoma Kinase Inhibitors Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Crtierium, Inc. Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Betta Pharmaceutcials Co., Ltd.
2.5.1 Business Overview
2.5.2 Anaplastic Lymphoma Kinase Inhibitors Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Betta Pharmaceutcials Co., Ltd. Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 F.Hoffman-La Roche Ltd.
2.6.1 Business Overview
2.6.2 Anaplastic Lymphoma Kinase Inhibitors Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 F.Hoffman-La Roche Ltd. Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Tesaro, Inc.
2.7.1 Business Overview
2.7.2 Anaplastic Lymphoma Kinase Inhibitors Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Tesaro, Inc. Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Oncoethix GmbH
2.8.1 Business Overview
2.8.2 Anaplastic Lymphoma Kinase Inhibitors Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Oncoethix GmbH Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Novartis AG.
2.9.1 Business Overview
2.9.2 Anaplastic Lymphoma Kinase Inhibitors Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis AG. Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Xcovery Holding Company, LLC
2.10.1 Business Overview
2.10.2 Anaplastic Lymphoma Kinase Inhibitors Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Xcovery Holding Company, LLC Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Anaplastic Lymphoma Kinase Inhibitors Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Anaplastic Lymphoma Kinase Inhibitors Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Anaplastic Lymphoma Kinase Inhibitors Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Anaplastic Lymphoma Kinase Inhibitors Manufacturer Market Share in 2018
3.3.2 Top 6 Anaplastic Lymphoma Kinase Inhibitors Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Anaplastic Lymphoma Kinase Inhibitors Market Analysis by Regions
4.1 Global Anaplastic Lymphoma Kinase Inhibitors Sales, Revenue and Market Share by Regions
4.1.1 Global Anaplastic Lymphoma Kinase Inhibitors Sales and Market Share by Regions (2014-2019)
4.1.2 Global Anaplastic Lymphoma Kinase Inhibitors Revenue and Market Share by Regions (2014-2019)
4.2 North America Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
4.3 Europe Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
4.5 South America Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
5 North America Anaplastic Lymphoma Kinase Inhibitors by Country
5.1 North America Anaplastic Lymphoma Kinase Inhibitors Sales, Revenue and Market Share by Country
5.1.1 North America Anaplastic Lymphoma Kinase Inhibitors Sales and Market Share by Country (2014-2019)
5.1.2 North America Anaplastic Lymphoma Kinase Inhibitors Revenue and Market Share by Country (2014-2019)
5.2 United States Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
5.3 Canada Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
5.4 Mexico Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
6 Europe Anaplastic Lymphoma Kinase Inhibitors by Country
6.1 Europe Anaplastic Lymphoma Kinase Inhibitors Sales, Revenue and Market Share by Country
6.1.1 Europe Anaplastic Lymphoma Kinase Inhibitors Sales and Market Share by Country (2014-2019)
6.1.2 Europe Anaplastic Lymphoma Kinase Inhibitors Revenue and Market Share by Country (2014-2019)
6.2 Germany Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
6.3 UK Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
6.4 France Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
6.5 Russia Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
6.6 Italy Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
7 Asia-Pacific Anaplastic Lymphoma Kinase Inhibitors by Country
7.1 Asia-Pacific Anaplastic Lymphoma Kinase Inhibitors Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Anaplastic Lymphoma Kinase Inhibitors Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Anaplastic Lymphoma Kinase Inhibitors Revenue and Market Share by Country (2014-2019)
7.2 China Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
7.3 Japan Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
7.4 Korea Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
7.5 India Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
8 South America Anaplastic Lymphoma Kinase Inhibitors by Country
8.1 South America Anaplastic Lymphoma Kinase Inhibitors Sales, Revenue and Market Share by Country
8.1.1 South America Anaplastic Lymphoma Kinase Inhibitors Sales and Market Share by Country (2014-2019)
8.1.2 South America Anaplastic Lymphoma Kinase Inhibitors Revenue and Market Share by Country (2014-2019)
8.2 Brazil Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
8.3 Argentina Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
8.4 Colombia Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
9 Middle East and Africa Anaplastic Lymphoma Kinase Inhibitors by Countries
9.1 Middle East and Africa Anaplastic Lymphoma Kinase Inhibitors Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Anaplastic Lymphoma Kinase Inhibitors Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Anaplastic Lymphoma Kinase Inhibitors Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
9.3 Turkey Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
9.4 Egypt Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
9.5 Nigeria Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
9.6 South Africa Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
10 Global Anaplastic Lymphoma Kinase Inhibitors Market Segment by Type
10.1 Global Anaplastic Lymphoma Kinase Inhibitors Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Anaplastic Lymphoma Kinase Inhibitors Sales and Market Share by Type (2014-2019)
10.1.2 Global Anaplastic Lymphoma Kinase Inhibitors Revenue and Market Share by Type (2014-2019)
10.2 Crizotinib Sales Growth and Price
10.2.1 Global Crizotinib Sales Growth (2014-2019)
10.2.2 Global Crizotinib Price (2014-2019)
10.3 Ceritinib Sales Growth and Price
10.3.1 Global Ceritinib Sales Growth (2014-2019)
10.3.2 Global Ceritinib Price (2014-2019)
10.4 Alectinib Hydrochloride Sales Growth and Price
10.4.1 Global Alectinib Hydrochloride Sales Growth (2014-2019)
10.4.2 Global Alectinib Hydrochloride Price (2014-2019)
11 Global Anaplastic Lymphoma Kinase Inhibitors Market Segment by Application
11.1 Global Anaplastic Lymphoma Kinase Inhibitors Sales Market Share by Application (2014-2019)
11.2 NSCLC Sales Growth (2014-2019)
11.3 Breast Cancer Sales Growth (2014-2019)
11.4 Colorectal Cancer Sales Growth (2014-2019)
11.5 Neuroblastoma Sales Growth (2014-2019)
11.6 Ovarian Cancer Sales Growth (2014-2019)
11.7 Others Sales Growth (2014-2019)
12 Anaplastic Lymphoma Kinase Inhibitors Market Forecast (2019-2024)
12.1 Global Anaplastic Lymphoma Kinase Inhibitors Sales, Revenue and Growth Rate (2019-2024)
12.2 Anaplastic Lymphoma Kinase Inhibitors Market Forecast by Regions (2019-2024)
12.2.1 North America Anaplastic Lymphoma Kinase Inhibitors Market Forecast (2019-2024)
12.2.2 Europe Anaplastic Lymphoma Kinase Inhibitors Market Forecast (2019-2024)
12.2.3 Asia-Pacific Anaplastic Lymphoma Kinase Inhibitors Market Forecast (2019-2024)
12.2.4 South America Anaplastic Lymphoma Kinase Inhibitors Market Forecast (2019-2024)
12.2.5 Middle East and Africa Anaplastic Lymphoma Kinase Inhibitors Market Forecast (2019-2024)
12.3 Anaplastic Lymphoma Kinase Inhibitors Market Forecast by Type (2019-2024)
12.3.1 Global Anaplastic Lymphoma Kinase Inhibitors Sales Forecast by Type (2019-2024)
12.3.2 Global Anaplastic Lymphoma Kinase Inhibitors Market Share Forecast by Type (2019-2024)
12.4 Anaplastic Lymphoma Kinase Inhibitors Market Forecast by Application (2019-2024)
12.4.1 Global Anaplastic Lymphoma Kinase Inhibitors Sales Forecast by Application (2019-2024)
12.4.2 Global Anaplastic Lymphoma Kinase Inhibitors Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Anaplastic Lymphoma Kinase Inhibitors Picture
Table Product Specifications of Anaplastic Lymphoma Kinase Inhibitors
Figure Global Sales Market Share of Anaplastic Lymphoma Kinase Inhibitors by Types in 2018
Table Anaplastic Lymphoma Kinase Inhibitors Types for Major Manufacturers
Figure Crizotinib Picture
Figure Ceritinib Picture
Figure Alectinib Hydrochloride Picture
Figure Anaplastic Lymphoma Kinase Inhibitors Sales Market Share by Applications in 2018
Figure NSCLC Picture
Figure Breast Cancer Picture
Figure Colorectal Cancer Picture
Figure Neuroblastoma Picture
Figure Ovarian Cancer Picture
Figure Others Picture
Figure United States Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure France Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure UK Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure China Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure India Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Anaplastic Lymphoma Kinase Inhibitors Revenue (Value) and Growth Rate (2014-2024)
Table Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer, Inc. Anaplastic Lymphoma Kinase Inhibitors Type and Applications
Table Pfizer, Inc. Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Co., Ltd. Anaplastic Lymphoma Kinase Inhibitors Type and Applications
Table Takeda Pharmaceutical Co., Ltd. Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Helsinn Therapeutics Basic Information, Manufacturing Base and Competitors
Table Helsinn Therapeutics Anaplastic Lymphoma Kinase Inhibitors Type and Applications
Table Helsinn Therapeutics Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Crtierium, Inc. Basic Information, Manufacturing Base and Competitors
Table Crtierium, Inc. Anaplastic Lymphoma Kinase Inhibitors Type and Applications
Table Crtierium, Inc. Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Betta Pharmaceutcials Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table Betta Pharmaceutcials Co., Ltd. Anaplastic Lymphoma Kinase Inhibitors Type and Applications
Table Betta Pharmaceutcials Co., Ltd. Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table F.Hoffman-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table F.Hoffman-La Roche Ltd. Anaplastic Lymphoma Kinase Inhibitors Type and Applications
Table F.Hoffman-La Roche Ltd. Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Tesaro, Inc. Basic Information, Manufacturing Base and Competitors
Table Tesaro, Inc. Anaplastic Lymphoma Kinase Inhibitors Type and Applications
Table Tesaro, Inc. Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Oncoethix GmbH Basic Information, Manufacturing Base and Competitors
Table Oncoethix GmbH Anaplastic Lymphoma Kinase Inhibitors Type and Applications
Table Oncoethix GmbH Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG. Basic Information, Manufacturing Base and Competitors
Table Novartis AG. Anaplastic Lymphoma Kinase Inhibitors Type and Applications
Table Novartis AG. Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Xcovery Holding Company, LLC Basic Information, Manufacturing Base and Competitors
Table Xcovery Holding Company, LLC Anaplastic Lymphoma Kinase Inhibitors Type and Applications
Table Xcovery Holding Company, LLC Anaplastic Lymphoma Kinase Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Anaplastic Lymphoma Kinase Inhibitors Sales by Manufacturer (2017-2018)
Figure Global Anaplastic Lymphoma Kinase Inhibitors Sales Market Share by Manufacturer in 2017
Figure Global Anaplastic Lymphoma Kinase Inhibitors Sales Market Share by Manufacturer in 2018
Table Global Anaplastic Lymphoma Kinase Inhibitors Revenue by Manufacturer (2017-2018)
Figure Global Anaplastic Lymphoma Kinase Inhibitors Revenue Market Share by Manufacturer in 2017
Figure Global Anaplastic Lymphoma Kinase Inhibitors Revenue Market Share by Manufacturer in 2018
Figure Top 3 Anaplastic Lymphoma Kinase Inhibitors Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Anaplastic Lymphoma Kinase Inhibitors Manufacturer (Revenue) Market Share in 2018
Figure Global Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Global Anaplastic Lymphoma Kinase Inhibitors Revenue and Growth Rate (2014-2019)
Table Global Anaplastic Lymphoma Kinase Inhibitors Sales by Regions (2014-2019)
Table Global Anaplastic Lymphoma Kinase Inhibitors Sales Market Share by Regions (2014-2019)
Table Global Anaplastic Lymphoma Kinase Inhibitors Revenue by Regions (2014-2019)
Figure Global Anaplastic Lymphoma Kinase Inhibitors Revenue Market Share by Regions (2014-2019)
Figure Global Anaplastic Lymphoma Kinase Inhibitors Revenue Market Share by Regions in 2018
Figure North America Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Europe Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure South America Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure North America Anaplastic Lymphoma Kinase Inhibitors Revenue and Growth Rate (2014-2019)
Table North America Anaplastic Lymphoma Kinase Inhibitors Sales by Countries (2014-2019)
Table North America Anaplastic Lymphoma Kinase Inhibitors Sales Market Share by Countries (2014-2019)
Figure North America Anaplastic Lymphoma Kinase Inhibitors Sales Market Share by Countries (2014-2019)
Figure North America Anaplastic Lymphoma Kinase Inhibitors Sales Market Share by Countries in 2018
Table North America Anaplastic Lymphoma Kinase Inhibitors Revenue by Countries (2014-2019)
Table North America Anaplastic Lymphoma Kinase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America Anaplastic Lymphoma Kinase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America Anaplastic Lymphoma Kinase Inhibitors Revenue Market Share by Countries in 2018
Figure United States Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Canada Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Mexico Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Europe Anaplastic Lymphoma Kinase Inhibitors Revenue and Growth Rate (2014-2019)
Table Europe Anaplastic Lymphoma Kinase Inhibitors Sales by Countries (2014-2019)
Table Europe Anaplastic Lymphoma Kinase Inhibitors Sales Market Share by Countries (2014-2019)
Table Europe Anaplastic Lymphoma Kinase Inhibitors Revenue by Countries (2014-2019)
Figure Europe Anaplastic Lymphoma Kinase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Europe Anaplastic Lymphoma Kinase Inhibitors Revenue Market Share by Countries in 2018
Figure Germany Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure UK Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure France Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Russia Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Italy Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Anaplastic Lymphoma Kinase Inhibitors Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Anaplastic Lymphoma Kinase Inhibitors Sales by Countries (2014-2019)
Table Asia-Pacific Anaplastic Lymphoma Kinase Inhibitors Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Anaplastic Lymphoma Kinase Inhibitors Sales Market Share by Countries 2018
Table Asia-Pacific Anaplastic Lymphoma Kinase Inhibitors Revenue by Countries (2014-2019)
Figure Asia-Pacific Anaplastic Lymphoma Kinase Inhibitors Revenue Market Share by Countries 2018
Figure China Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Japan Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Korea Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure India Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Southeast Asia Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure South America Anaplastic Lymphoma Kinase Inhibitors Revenue and Growth Rate (2014-2019)
Table South America Anaplastic Lymphoma Kinase Inhibitors Sales by Countries (2014-2019)
Table South America Anaplastic Lymphoma Kinase Inhibitors Sales Market Share by Countries (2014-2019)
Figure South America Anaplastic Lymphoma Kinase Inhibitors Sales Market Share by Countries in 2018
Table South America Anaplastic Lymphoma Kinase Inhibitors Revenue by Countries (2014-2019)
Table South America Anaplastic Lymphoma Kinase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure South America Anaplastic Lymphoma Kinase Inhibitors Revenue Market Share by Countries in 2018
Figure Brazil Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Argentina Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Colombia Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Anaplastic Lymphoma Kinase Inhibitors Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Anaplastic Lymphoma Kinase Inhibitors Sales by Countries (2014-2019)
Table Middle East and Africa Anaplastic Lymphoma Kinase Inhibitors Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Anaplastic Lymphoma Kinase Inhibitors Sales Market Share by Countries in 2018
Table Middle East and Africa Anaplastic Lymphoma Kinase Inhibitors Revenue by Countries (2014-2019)
Table Middle East and Africa Anaplastic Lymphoma Kinase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anaplastic Lymphoma Kinase Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anaplastic Lymphoma Kinase Inhibitors Revenue Market Share by Countries in 2018
Figure Saudi Arabia Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure UAE Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Egypt Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure Nigeria Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Figure South Africa Anaplastic Lymphoma Kinase Inhibitors Sales and Growth Rate (2014-2019)
Table Global Anaplastic Lymphoma Kinase Inhibitors Sales by Type (2014-2019)
Table Global Anaplastic Lymphoma Kinase Inhibitors Sales Share by Type (2014-2019)
Table Global Anaplastic Lymphoma Kinase Inhibitors Revenue by Type (2014-2019)
Table Global Anaplastic Lymphoma Kinase Inhibitors Revenue Share by Type (2014-2019)
Figure Global Crizotinib Sales Growth (2014-2019)
Figure Global Crizotinib Price (2014-2019)
Figure Global Ceritinib Sales Growth (2014-2019)
Figure Global Ceritinib Price (2014-2019)
Figure Global Alectinib Hydrochloride Sales Growth (2014-2019)
Figure Global Alectinib Hydrochloride Price (2014-2019)
Table Global Anaplastic Lymphoma Kinase Inhibitors Sales by Application (2014-2019)
Table Global Anaplastic Lymphoma Kinase Inhibitors Sales Share by Application (2014-2019)
Figure Global NSCLC Sales Growth (2014-2019)
Figure Global Breast Cancer Sales Growth (2014-2019)
Figure Global Colorectal Cancer Sales Growth (2014-2019)
Figure Global Neuroblastoma Sales Growth (2014-2019)
Figure Global Ovarian Cancer Sales Growth (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Anaplastic Lymphoma Kinase Inhibitors Sales, Revenue and Growth Rate (2019-2024)
Table Global Anaplastic Lymphoma Kinase Inhibitors Sales Forecast by Regions (2019-2024)
Table Global Anaplastic Lymphoma Kinase Inhibitors Market Share Forecast by Regions (2019-2024)
Figure North America Sales Anaplastic Lymphoma Kinase Inhibitors Market Forecast (2019-2024)
Figure Europe Sales Anaplastic Lymphoma Kinase Inhibitors Market Forecast (2019-2024)
Figure Asia-Pacific Sales Anaplastic Lymphoma Kinase Inhibitors Market Forecast (2019-2024)
Figure South America Sales Anaplastic Lymphoma Kinase Inhibitors Market Forecast (2019-2024)
Figure Middle East and Africa Sales Anaplastic Lymphoma Kinase Inhibitors Market Forecast (2019-2024)
Table Global Anaplastic Lymphoma Kinase Inhibitors Sales Forecast by Type (2019-2024)
Table Global Anaplastic Lymphoma Kinase Inhibitors Market Share Forecast by Type (2019-2024)
Table Global Anaplastic Lymphoma Kinase Inhibitors Sales Forecast by Application (2019-2024)
Table Global Anaplastic Lymphoma Kinase Inhibitors Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
甲状腺未分化がん用薬市場：世界及び中国市場分析・予測（～2024年） Anaplastic Thyroid Cancer Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Anaplastic Thyroid Cancer Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Anaplast…- 卵巣がん治療薬市場：世界及び中国市場分析・予測（～2024年） Ovarian Cancer Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Ovarian Cancer Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ovarian Cancer Drugs manufac…
- 卵巣がん治療法市場：世界及び中国市場分析・予測（～2024年） Ovarian Cancer Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Ovarian Cancer Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ovarian Cancer…
- 卵巣がん治療＆診断の世界市場 2019年版：種類別（手術、放射線療法、薬物治療）、用途別（病院、クリニック、その他） Scope of the Report: The global Therapies and Diagnostics for Ovarian Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, e…
- 大腸がん診断＆治療市場：世界及び中国市場分析・予測（～2024年） Colorectal Cancer Diagnosis and Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Colorectal Cancer Diagnosis and Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the m…